NCT04947384Withdrawn
Pulmonary Vascular Hemodynamics Before and After Mitral Valve Procedures
Source: ClinicalTrials.gov · Last updated 27 Jan 2026
Reason given: PI moved to a different institution. Low enrollment rate.
Brief summary (registry, in English)
The objective of this proposal is to study circulating and echocardiographic markers of pulmonary vascular and right ventricular remodeling in patients with a WHO-2 diagnosis of pulmonary hypertension after mitral valve procedures. The investigators are proposing the study will be impactful for the early detection and prediction and of residual pulmonary hypertension (PH) that would otherwise be undetected and fatal with no curative treatment.
- Status (registry)
- Withdrawn
- Study type
- Observational
- Enrollment
- 0 (actual)
- First submitted
- 18 May 2021
- Start date
- 21 Dec 2021
- Primary completion date
- 20 Dec 2025
- Lead sponsor
- University of Alabama at Birmingham
- Diseases
- Pulmonary arterial hypertension
- NCT number
- NCT04947384
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Transplant patients
Other illness
- Any aortic valvular disease
Lab values
- Patients with ejection fraction (EF) < 35%
- Patients with a diagnosis of heart failure with preserved ejection fraction
Other
- Patients with severe tricuspid valve regurgitation
- Patients scheduled for ventricular assist devices
Who the study is looking for
- >= 18 years/old
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Alabama at Birmingham | Birmingham | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.